Broadwood Partners, L.P.

Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Buy(P)251K$3.64$913K12.7M
Apr 27, 2026Buy(P)0$012.7M
Apr 24, 2026Buy(P)39K$3.53$137K12.4M
Apr 24, 2026Buy(P)0$012.4M
Apr 23, 2026Buy(P)280K$3.50$982K12.4M
Apr 23, 2026Buy(P)0$012.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-26-002414) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about IMDX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000919574-26-002414"
Ask your agent
Use Arkolith to summarize insider buying and selling at Insight Molecular Diagnostics Inc.
over the last 90 days and cite the filings.